文献速递新发突发、热带与寄生虫病

婴儿期疟疾临床表型的年龄相关变化受镰状细胞特质修饰

Age-Related Changes in Malaria Clinical Phenotypes During Infancy Are Modified by Sickle Cell Trait.
PubMed 文献 · Clin Infect Dis · 2021-01-01

在乌干达高疟疾传播区纳入678名婴儿出生队列随访至12月龄,发现症状性疟疾发病率从0-<6月龄的1.2例/人年升至6-12月龄的2.6例/人年,无症状寄生虫血症月概率从32%降至21%。HbAS对症状性疟疾有保护作用(IRR=0.57,95%CI 0.44-0.74,P<0.001),但保护效应随年龄非线性变化(Pint<0.001)。

要点

  • 婴儿症状性疟疾发病率随月龄增加而上升,无症状寄生虫血症概率下降。
  • HbAS对症状性疟疾总体有保护作用,但保护效应随年龄非线性变化。
  • HbAS婴儿在高寄生虫密度时耐受无热能力降低。

核心结论

  • 婴儿期HbAS保护效能的年龄依赖变化伴随HbAS与HbAA婴儿抗寄生虫和抗疾病保护的差异性丢失。

研究设计与样本

  • 在乌干达Busia高疟疾传播区纳入678名婴儿的出生队列,随访至12月龄,量化对寄生虫血症和临床疾病的保护。

主要发现

  • 症状性疟疾发病率在0-<6月龄为1.2例/人年,6-12月龄为2.6例/人年。
  • 给定感染时无症状寄生虫血症的月概率从32%降至21%。
  • HbAS对比HbAA的症状性疟疾发病率比IRR=0.57(95%CI 0.44-0.74,P<0.001)。
  • 年龄修饰HbAS与症状性疟疾关系(Pint<0.001),保护在0-9月龄间减弱后增加。
  • 年龄增长与感染时更高寄生虫密度相关,HbAS婴儿耐受高密度无热能力降低。

临床怎么用

  • 婴儿期疟疾防护需考虑年龄相关的临床表型变化及HbAS状态对保护效应的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infants are protected against Plasmodium falciparum malaria. Mechanisms that drive this protection remain unclear due to a poor understanding of malaria clinical phenotypes during infancy. METHODS: We enrolled a birth cohort of 678 infants in Busia, Uganda, an area of high malaria transmission. We followed infants through 12 months of age and quantified protection against parasitemia and clinical disease. RESULTS: Symptomatic malaria incidence increased from 1.2 to 2.6 episodes per person-year between 0 and <6 months and between 6 and 12 months of age, while the monthly probability of asymptomatic parasitemia given infection decreased from 32% to 21%. Sickle cell trait (HbAS) was protective against symptomatic malaria (incidence rate ratio = 0.57 comparing HbAS vs hemoglobin AA (HbAA); 95% confidence interval, 0.44-0.74; P < .001), but age modified this relationship (Pint = <0.001), with nonlinear protection that waned between 0 and 9 months of age before increasing. Increasing age was associated with higher parasite densities at the time of infection and, in infants with HbAS, a reduced ability to tolerate high parasite densities without fever. CONCLUSIONS: Age-dependent changes in HbAS protective efficacy in infancy were accompanied by differential loss of antiparasite and antidisease protection among HbAS and HbAA infants. This provides a framework for investigating the mechanisms that underlie infant protection against malaria. CLINICAL TRIALS REGISTRATION: NCT02793622.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Zehner N, Adrama H, Kakuru A, et al. Age-Related Changes in Malaria Clinical Phenotypes During Infancy Are Modified by Sickle Cell Trait. Clin Infect Dis. 2021. PMID: 33738485. doi:10.1093/cid/ciab245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。